Form D · Biotechnology

AFFYMAX INC

Palo Alto, CA · CIK 0001158223

Offering snapshot reported Mar 3, 2009 · SEC filing

Reported sold
$42M
Offering amount: $42M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 3, 2009Initial$41,999,999No comparisonNot reportedSEC filing
Oct 23, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Mar 8, 2006PaperNot reportedNo comparisonNot reported
Jul 25, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-55801

Source: Form D, filed Mar 3, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Paul Cleveland Executive
R. Lee Douglas Director
Anne Marie Duliege Executive
Nicholas Galakatos Director
Kathleen La Porte Director
Keith Leonard Director
Ted W. Love Director
Steven Love Executive
Arlene Morris Director, Executive
Daniel Spiegelman Director
Christi Va Heek Director
Robert Venteicher Executive
John Walker Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4001 Miranda Ave
Palo Alto, CA, 94304